Clinical Trial: A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224425) titled 'A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps' on Nov. 03.

Brief Summary: This study is open to adults with advanced cancer (solid tumours) for whom previous treatment was not successful, or no treatment exists. The study tests different doses of BI 3810944 to find out which doses they can tolerate. Another purpose is to identify the most suitable dose of BI 3810944 and to find out whether it helps people with advanced cancer. BI 3810944 may help fight cancer.

Participants get BI 3810944 usually once every 3 weeks. At treatment start, it is given once a ...